Global Ganja Report

Following the crackdown on CBD-infused foods and beverages by authorities in New York City and elsewhere, Capitol Hill lawmakers are formally calling upon the FDA to provide immediate clarity on the question. Meanwhile, New York, at least is starting to lift the pressure.

After what has been an agonizing delay for many patients, Louisiana's first medical marijuana harvest has just cleared inspection. But there are still more hurdles before the first extracts and tinctures will begin arriving in the state's nine approved pharmacies. 

A bill that would legalize "recreational" cannabis is moving forward in Hawaii's state legislature. It would build on the dispensary system established by the state's medical marijuana program to bring about a regulated adult-use market.

CBD-infused foods and beverages are the target of a crackdown in New York City, as well as Maine and Ohio. A budding business of cannabinoid-enhanced concoctions and libations is feeling a sudden pinch. But some media coverage is failing to make clear that what is at issue here is the FDA's failure to keep pace with federal law—not any inherent risks of cannabidiol.

Already officially studying the possibility of cannabis legalization, Mexico's new President López Obrador has now announced a formal end to the "war on drugs" that has only seemed to fuel the narco-violence over the past 10 years.  However, military troops are still being mobilized for narcotics enforcement—including marijuana eradication.

With Oregon's cannabis surplus so big that authorities estimate 70% of the state's output goes unsold, "craft" producers are calling for a novel solution—allowing export to other states that have legalized.

The cannabis market is flooded in the Beaver State, and that's a real problem for an industry that has seen explosive growth since Oregonians voted to legalize in 2014. But some say this provides an opportunity.

Israel's internal market for medical cannabis products is limited by the country's relatively small population, but with exports now approved by the cabinet, a multi-billion-dollar industry is foreseen. Since the announcement, share prices of cannabis companies on the Tel Aviv Stock Exchange have soared.

The World Health Organization has released its long-anticipated recommendation on cannabis scheduling. But rather than removing it from Schedule I of the Single Convention, it only removes it from Schedule IV, where it is also listed. CBD, however, has indeed been de-scheduled entirely.